|
|
| (11) | Number of the document | C 1725537 |
| (68) | Number of the document | 1725537 |
| (21) | Application number for Supplementary Protection Certificate | PA 2017 005 |
| (22) | Date of filing the application | 2017-03-01 |
| (41) | Date of publication of the application | 2017-03-27 |
| Date of publication of SPC | 2018-02-26 | |
| (24) | Date of coming into effect of SPC | 2025-03-15 |
| (71) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/16/1126, 2016-09-19 |
| (94) | 2030-03-14 |
| (95) | Eluksadolinas arba jo farmaciniu požiūriu priimtinas enantiomeras, diastereomeras, racematas arba druska |
| SPC lapsed (non-payment of fees for the main patent) | ||
| Date of negative decision to issue the SPC | 2023-03-14 |